AnalystsLaura ChicoLaura Chico's Stock Forecasts
AnalystsLaura Chico
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#3988 out of 4204 analysts
Average Return
-22.31%
Win Rate
24%9 out of 37
Risk vs Reward
Poor
Good
Laura Chico's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | +119.38% | $27.61 | $60.57 | 2019-12-17 - 2020-12-18 | Buy |
Xenon Pharmaceuticals IncXENE | +59.29% | $11.25 | $17.92 | 2020-03-24 - 2021-03-25 | Buy |
Pepgen IncPEPG | +51.56% | $11.19 | $16.96 | 2022-05-31 - 2023-03-20 | Buy |
Vigil Neuroscience IncVIGL | +18.19% | $8.63 | $10.20 | 2022-09-15 - 2023-03-20 | Buy |
Karuna Therapeutics IncKRTX | +17.12% | $92.43 | $108.25 | 2020-06-02 - 2021-06-02 | Buy |
Laura Chico Analyst Color
Get additional color on Laura Chico's coverage of popular stocks
Laura Chico's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Stoke Therapeutics IncSTOK | 4 | Buy | $25.00 | +206.00% | Maintains | 15 days ago |
Ardelyx IncARDX | 3 | Buy | $6.00 | +54.64% | Upgrades | 19 days ago |
Denali Therapeutics IncDNLI | 1 | Buy | $38.00 | +62.88% | Maintains | 22 days ago |
Travere Therapeutics IncTVTX | 2 | Buy | $30.00 | +42.99% | Upgrades | a month ago |
Neurocrine Biosciences IncNBIX | 3 | Buy | $131.00 | +34.76% | Maintains | a month ago |
Vera Therapeutics IncVERA | 2 | Hold | $8.00 | +6.95% | Downgrades | 3 months ago |
Biogen IncBIIB | 4 | Hold | $247.00 | -7.80% | Maintains | 4 months ago |
Impel Pharmaceuticals IncIMPL | 2 | Hold | $5.00 | +400.00% | Downgrades | 4 months ago |
Vigil Neuroscience IncVIGL | 1 | Buy | $19.00 | +86.27% | Initiates Coverage On | 6 months ago |
Apellis Pharmaceuticals IncAPLS | 4 | Hold | $67.00 | +6.26% | Maintains | 6 months ago |
Taysha Gene Therapies IncTSHA | 2 | Buy | $5.00 | +600.28% | Maintains | 7 months ago |
Design Therapeutics IncDSGN | 2 | Buy | $26.00 | +298.77% | Maintains | 7 months ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Hold | $148.50 | -2.17% | Downgrades | 7 months ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $41.00 | +18.50% | Maintains | 9 months ago |
Pepgen IncPEPG | 1 | Buy | $17.00 | +0.24% | Initiates Coverage On | 10 months ago |
Longboard Pharmaceuticals IncLBPH | 1 | Buy | $14.00 | N/A | Initiates Coverage On | a year ago |
Astria Therapeutics IncATXS | 1 | Buy | $16.00 | N/A | Initiates Coverage On | 2 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Hold | $91.00 | N/A | Maintains | 2 years ago |
Edgewise Therapeutics IncEWTX | 1 | Buy | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Viela Bio IncVIE | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Voyager Therapeutics IncVYGR | 1 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Chinook Therapeutics IncKDNY | 1 | Buy | $28.00 | N/A | Initiates Coverage On | 2 years ago |
Praxis Precision Medicines IncPRAX | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Karuna Therapeutics IncKRTX | 1 | Buy | $126.00 | N/A | Maintains | 3 years ago |
Sage Therapeutics IncSAGE | 1 | Hold | $37.00 | N/A | Downgrades | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 3 | Buy | $110.00 | N/A | Reinstates | 4 years ago |
Acer Therapeutics IncACER | 2 | Buy | $40.00 | N/A | Reinstates | 4 years ago |
Paratek Pharmaceuticals IncPRTK | 2 | Buy | N/A | N/A | Downgrades | 5 years ago |
Bioverativ IncBIVV | 1 | Hold | N/A | N/A | Downgrades | 5 years ago |
Corbus Pharmaceuticals Holdings IncCRBP | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Acorda Therapeutics IncACOR | 1 | Sell | N/A | N/A | Downgrades | 5 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $14.00 | N/A | Initiates Coverage On | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.